Mary Pasquinelli, DNP, to receive James L. Mulshine, M.D., National Leadership Award for her establishment of lung cancer screening program

Nov 3, 2021

Pour diffusion immédiate

Lisa Berry Edwards
Directeur général, Affaires extérieures
Fondation Prévenir le Cancer
lisa.edwards@preventcancer.org
703-519-2107

Alexandria, Va. (Nov. 3, 2021) — Mary Pasquinelli, DNP, a specialist in pulmonary and medical oncology based in Chicago, will receive the James L. Mulshine, M.D., National Leadership Award on Thursday, November 4. This award is given annually to an individual who has had a profound impact on reducing the toll of early thoracic disease on the health of Americans and people around the world. Pasquinelli is being honored for her work establishing a lung cancer screening program to benefit medically underserved communities.

La Fondation Prévenir le Cancer^® will present the ninth Mulshine Award at the 18^ème annuel Atelier d'imagerie quantitative. The workshop focuses on the advancement of the use of quantitative low-dose computerized tomography (LDCT) for detection and management of early thoracic disease—lung cancer, COPD and cardiovascular disease—three of the top four leading causes of death in the U.S.

The lung cancer screening program Dr. Pasquinelli created is at a federally qualified health center on the West Side of Chicago. Additionally, she published a series of highly regarded papers on her team’s screening activities with a deep interest in overcoming health disparities through the implementation of lung cancer screening.

“The James L. Mulshine, M.D., National Leadership Award allows us to recognize someone in the medical community whose significant contributions are creating better outcomes for those with or at increased risk of developing lung cancer, COPD or cardiovascular disease,” said Carolyn Aldigé, founder and CEO of the Prevent Cancer Foundation. “Our award winners, including this year’s winner, Mary Pasquinelli, have worked hard to make our world a better place, and they should be honored accordingly.”

Past recipients of the award:

2020 – Daniel C. Sullivan, MD pour son travail de création et de présidence de la Quantitative Imaging Biomarkers Alliance (QIBA). QIBA s'engage à transformer les soins aux patients en faisant de la radiologie une science plus quantitative.
2019 – Andrew C. von Eschenbach, MD, ancien directeur du National Cancer Institute, pour sa conception, sa mise en œuvre et sa gestion de l'essai clinique le plus vaste et le plus coûteux de son histoire, le National Lung Screening Trial (NLST).
2018 – Sharon Y. Eubanks, du ministère américain de la Justice, pour son travail en tant que procureure principale du ministère de la Justice dans le procès historique pour racket contre Big Tobacco, une affaire qui a défié les pronostics et a été remportée par le gouvernement.
2017 – Feu John Walsh, président et chef de la direction de la Fondation COPD et président et fondateur de la Fondation Alpha One.
2016 – Laurie Fenton Ambrose, présidente et directrice générale de la Lung Cancer Alliance, pour ses efforts visant à guider les groupes de défense des patients dans leurs efforts visant à obtenir une couverture du dépistage du cancer du poumon par les Centers for Medicare & Medicaid Services (CMS).
2015 – Claudia Henschke, Ph.D., MD, Mt. Sinai Medical Center, en tant que pionnière de l'utilisation de la tomodensitométrie en spirale à faible dose pour dépister le cancer du poumon.
2014 – CVS Health, prix accepté par Nancy Gagliano, MD, directrice médicale de CVS, en reconnaissance de la décision audacieuse de l'entreprise de mettre fin à la vente de produits du tabac dans ses magasins.
2013 (Inaugural year of the Award) – Cheryl G. Healton, DrPH, President and CEO, Legacy Foundation and Dean of the College of Public Health at New York University, in recognition of over 25 years of tireless work in public health, specifically on tobacco control.

This year’s workshop will take place November 4-5 as a virtual event, with the award ceremony happening on November 4. Registration is closed, but those interested can view a recording of the award ceremony on November 5.

For more information about the Quantitative Imaging Workshop and the award, visit the Prevent Cancer Foundation website.

###

À propos de la Fondation Prévenir le Cancer^®

La Fondation Prévenir le Cancer^® is celebrating 35 years as the only U.S. nonprofit organization focused solely on saving lives across all populations through cancer prevention and early detection. Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated.

The Foundation is rising to meet the challenge of reducing cancer deaths by 40% by 2035. To achieve this, we are committed to investing $20 million for innovative technologies to detect cancer early and advance multi-cancer screening, $10 million to expand cancer screening and vaccination access to medically underserved communities, and $10 million to educate the public about screening and vaccination options. For more information, please visit www.preventcancer.org.